Purpose: To develop bioadhesive tablets of diltiazem hydrochloride with a unique combination of bioadhesion and drug release.Method: Tablets were prepared by physical blending of diltiazem hydrochloride with two polymers, viz., carbopol and hydroxylpropyl methyl cellulose in different ratio along with other excipients. A 32 central composite design was employed to optimize the formulations on the basis of phycochemical properties, bioadhesive strength (measured as force of detachment from gastric mucosa) and in vitro drug release. HPMC K 4M and Carbopol 934P were taken as the independent variables. Contour plots were drawn and optimum formulations were selected by feasibility and grid searches.Results: The tablets showed excellent bioadhesi...
The current study involves development of oral bioadhesive hydrophilic matrices of hydralazine hydro...
Objective: The objective of present study was to formulate an oral mcoadhesive tablet of diltiazem h...
AbstractLamotrigine is a BCS class II drug with pH dependent solubility. The bilayered gastric mucoa...
Purpose: To develop bioadhesive tablets of diltiazem hydrochloride with a unique combination of bioa...
The aim of present research work is to formulate and evaluate controlled release floating tablet of ...
The investigation was concerned with design and characterization of oral sustained release gastro re...
Purpose: To develop and optimise sustained release (SR) matrix tablets of diltiazem hydrochloride (D...
Objective: Floating bioadhesive tablets of hydrochlorothiazide were developed to prolong gastric res...
The gastroretentive dosage forms have potential for use as controlled-release drug delivery systems....
New era of novel drug delivery system oriented towards increasing safety and efficacy of existing dr...
The aim of the present study was to prepare and characterize controlled-release matrix tablets of Di...
Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using karaya g...
Purpose: To evaluate the effect of formulation variables on the bioadhesion and release properties o...
Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using karaya g...
Ranitidine HCl, a selective, competitive histamine H2-receptor antagonist with a short biological ha...
The current study involves development of oral bioadhesive hydrophilic matrices of hydralazine hydro...
Objective: The objective of present study was to formulate an oral mcoadhesive tablet of diltiazem h...
AbstractLamotrigine is a BCS class II drug with pH dependent solubility. The bilayered gastric mucoa...
Purpose: To develop bioadhesive tablets of diltiazem hydrochloride with a unique combination of bioa...
The aim of present research work is to formulate and evaluate controlled release floating tablet of ...
The investigation was concerned with design and characterization of oral sustained release gastro re...
Purpose: To develop and optimise sustained release (SR) matrix tablets of diltiazem hydrochloride (D...
Objective: Floating bioadhesive tablets of hydrochlorothiazide were developed to prolong gastric res...
The gastroretentive dosage forms have potential for use as controlled-release drug delivery systems....
New era of novel drug delivery system oriented towards increasing safety and efficacy of existing dr...
The aim of the present study was to prepare and characterize controlled-release matrix tablets of Di...
Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using karaya g...
Purpose: To evaluate the effect of formulation variables on the bioadhesion and release properties o...
Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using karaya g...
Ranitidine HCl, a selective, competitive histamine H2-receptor antagonist with a short biological ha...
The current study involves development of oral bioadhesive hydrophilic matrices of hydralazine hydro...
Objective: The objective of present study was to formulate an oral mcoadhesive tablet of diltiazem h...
AbstractLamotrigine is a BCS class II drug with pH dependent solubility. The bilayered gastric mucoa...